Varda and United Therapeutics announce pulmonary disease research collaboration
Varda Space Industries →Varda and United Therapeutics announced a research collaboration focused on pharmaceutical formulations for rare pulmonary disease. The companies planned to process small molecule compounds aboard Varda's orbital manufacturing and reentry platform, using microgravity to study crystallization and material structure. The work aims to explore improvements in stability, bioavailability and delivery characteristics, with samples returned to Earth for analysis. Varda contributes its spacecraft, processing capabilities and return capsules, while United Therapeutics contributes drug development expertise. Chief Science Officer Adrian Radocea described the goal as differentiated formulations. The announcement establishes a research program and potential therapeutic benefits, not an approved medicine, completed clinical trial or confirmed improvement in patient outcomes.